Mechanisms Involved in the Low-Level Regeneration of CD4+ Cells in HIV-1—Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads

Background. Persistent low CD4+ cell counts are observed in 5%–27% of patients treated for human immunodeficiency virus (HIV)—1 infection despite their having prolonged undetectable plasma viral loads. Methods. To understand the possible mechanisms of this discordant immunological situation, a prosp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 2005-05, Vol.191 (10), p.1670-1679
Hauptverfasser: Benveniste, Olivier, Flahault, Antoine, Rollot, Florence, Elbim, Carole, Estaquier, Jérôme, Pédron, Béatrice, Duval, Xavier, Dereuddre-Bosquet, Nathalie, Clayette, Pascal, Sterkers, Ghislaine, Simon, Anne, Ameisen, Jean-Claude, Leport, Catherine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background. Persistent low CD4+ cell counts are observed in 5%–27% of patients treated for human immunodeficiency virus (HIV)—1 infection despite their having prolonged undetectable plasma viral loads. Methods. To understand the possible mechanisms of this discordant immunological situation, a prospective transsectional case-control study was designed. HIV-1—infected subjects who had a plasma viral load 1 year were considered to be case patients if their CD4+ cell count was 500/mm3 and were matched by sex, age, and nadir CD4+ cell count to case patients. T cell proliferation after stimulation with various antigens, T cell subset counts, T cell rearrangement excision circles (TRECs), T cells undergoing apoptosis, cytokines influencing apoptosis, and cellular proviral DNA and plasma viral RNA persistence were assessed. Results. Compared with the 19 control patients, the 19 case patients had undistinguishable lymphoproliferative responses to candidin and cytomegalovirus, fewer naive CD4+ cells (CD45RA+62L+, 23%±13% vs. 47%±14%; P
ISSN:0022-1899
1537-6613
DOI:10.1086/429670